FAVERIO, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 7.135
EU - Europa 3.209
AS - Asia 861
SA - Sud America 15
OC - Oceania 12
AF - Africa 6
Totale 11.238
Nazione #
US - Stati Uniti d'America 7.068
IT - Italia 879
DE - Germania 729
SE - Svezia 553
IE - Irlanda 470
CN - Cina 458
HK - Hong Kong 187
GB - Regno Unito 150
UA - Ucraina 91
CA - Canada 65
VN - Vietnam 65
AT - Austria 60
FI - Finlandia 59
FR - Francia 52
IN - India 52
RU - Federazione Russa 47
DK - Danimarca 40
BE - Belgio 29
TR - Turchia 26
NL - Olanda 19
JP - Giappone 16
SG - Singapore 15
IR - Iran 9
AU - Australia 8
MN - Mongolia 7
CL - Cile 6
KR - Corea 6
PK - Pakistan 6
RO - Romania 5
BR - Brasile 4
CH - Svizzera 4
GR - Grecia 4
NZ - Nuova Zelanda 4
SC - Seychelles 4
BD - Bangladesh 3
BG - Bulgaria 3
ES - Italia 3
IL - Israele 3
PL - Polonia 3
AR - Argentina 2
CO - Colombia 2
PT - Portogallo 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
EE - Estonia 1
EG - Egitto 1
HU - Ungheria 1
IQ - Iraq 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
MU - Mauritius 1
MX - Messico 1
MY - Malesia 1
PE - Perù 1
PH - Filippine 1
RS - Serbia 1
SV - El Salvador 1
TW - Taiwan 1
Totale 11.238
Città #
Ann Arbor 2.176
Fairfield 687
Chandler 678
Frankfurt am Main 576
Dublin 456
Wilmington 414
Ashburn 387
Houston 339
Woodbridge 307
Seattle 254
New York 230
Milan 223
Cambridge 203
Hong Kong 187
Princeton 172
Dearborn 155
Altamura 85
Lawrence 80
Jacksonville 78
Nanjing 78
Shanghai 73
Fremont 58
Vienna 56
Beijing 53
Boardman 49
Helsinki 46
San Diego 46
Guangzhou 45
London 38
Dong Ket 35
Toronto 28
Brussels 27
Rome 26
Andover 23
Jinan 23
Monza 23
Nanchang 22
Lissone 20
Hangzhou 19
Chicago 16
Falls Church 15
Jiaxing 14
Hebei 13
Ningbo 13
Tianjin 13
Genoa 12
Pune 12
Ottawa 11
Shenyang 10
Kocaeli 9
Norwalk 9
Zhengzhou 9
Bologna 8
Brescia 8
Changsha 8
Groningen 8
Palermo 8
Turin 8
Washington 8
Carate Brianza 7
Edmonton 7
Lachine 7
Leawood 7
Singapore 7
Kunming 6
Los Angeles 6
Moscow 6
Paris 6
Taizhou 6
Atlanta 5
Desio 5
Faisalabad 5
Hefei 5
Kiev 5
Marietta 5
Reggio Nell'emilia 5
Rovereto 5
San Mateo 5
Tappahannock 5
Upper Marlboro 5
Vigevano 5
Auckland 4
Bonndorf 4
Castrolibero 4
Cincinnati 4
Cologne 4
Columbus 4
Lappeenranta 4
Nürnberg 4
Padova 4
Sacramento 4
San Giuliano Milanese 4
Tokyo 4
Varese 4
Wuhan 4
Abano Terme 3
Amsterdam 3
Buccinasco 3
Bupyeong-gu 3
Catania 3
Totale 8.883
Nome #
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 321
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study 298
Noninvasive ventilation weaning in acute hypercapnic respiratory failure due to COPD exacerbation: A real-life observational study 282
Progressive fibrosing interstitial lung diseases: prevalence and characterization in two Italian referral centers 273
Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights 272
Characterizing non-tuberculous mycobacteria infection in bronchiectasis 265
Early referral to palliative care services in patients with IPF: A tool to take a step forward 263
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 224
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 219
Rehospitalization for pneumonia after first pneumonia admission: Incidence and predictors in a population-based cohort study 206
Response to: Comment on "Noninvasive Ventilation Weaning in Acute Hypercapnic Respiratory Failure due to COPD Exacerbation: A Real-Life Observational Study" 191
Influenza A/H1N1 severe pneumonia: Novel morphocytological findings in bronchoalveolar lavage 182
Impact of traffic-related air pollution on pulmonary oxidative stress 178
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 178
Progression of obstructive ventilatory disorder in Fabry disease: Only a matter of time? 176
Corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A single center experience and literature review 175
Interstitial Pneumonia with Autoimmune Features: Why Rheumatologist-Pulmonologist Collaboration Is Essential 174
Janus-faced amiodarone-induced pneumopathy 168
A 61-year-old female with chronic cough and purulent sputum 166
Prolonged exposure to welding fumes as a novel cause of systemic iron overload 159
Management of acute respiratory failure in interstitial lung diseases: Overview and clinical insights 156
Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: Do we need a personalized approach? 153
Hospital admission decision for patients with community-acquired pneumonia 150
Clinical differences in sarcoidosis patients with and without lymphoma: A single-centre retrospective cohort analysis 148
Inpatient Care during the COVID-19 Pandemic: A Survey of Italian Physicians 147
Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy 146
Non-tuberculous mycobacteria pulmonary disease: an integrated approach beyond antibiotics 146
An unusual presentation of pulmonary lymphoma: When diffuse ground glass opacities can mean anything 145
Systemic sclerosis and outcome in intensive care unit: Do not close the door, open the right protocol 143
Non-specific interstitial pneumonia and features of connective tissue disease: What are the consequences of a different point of view? 143
Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis 139
Long-term prognosis in community-acquired pneumonia 132
Allergic bronchopulmonary aspergillosis screening in bronchiectasis: Is there always a precise answer to a clear question? 130
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: An international case-cohort study 130
Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study 128
Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: A multinational point prevalence study of hospitalised patients 125
The management of community-acquired pneumonia in the elderly 124
Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia 124
Phenotyping in Bronchiectasis: Are we moving towards a personalized medicine? 123
Covid-19 and the role of smoking: The protocol of the multicentric prospective study COSMO-IT (covid19 and smoking in italy) 123
Thrombocytosis during Stable State Predicts Mortality in Bronchiectasis 119
Mapping the human genetic architecture of COVID-19 119
Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study 118
Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia 118
Macrolidi a lungo termine nella broncopneumopatia cronica ostruttiva 115
Serum and exhaled breath condensate inflammatory cytokines in community-acquired pneumonia: a prospective cohort study 115
History of lung volume reduction procedures 115
Increasing prevalence of chronic lung disease in veterans of the wars in Iraq and Afghanistan 114
Economic impact of anti-IL-5 agents in patients with severe eosinophilic asthma: A population-based cohort study 110
Noninvasive ventilation for acute respiratory failure due to community-acquired pneumonia: A concise review and update 110
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 107
Obstructive sleep apnea is associated with higher healthcare utilization in elderly patients 105
Individualizing duration of antibiotic therapy in community-acquired pneumonia 105
Non-tuberculous Mycobacterial Pulmonary Disease: an Italian National Survey 104
Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study 104
International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia 101
One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study 100
Streptococcus pneumoniae translocates into the myocardium and forms unique microlesions that disrupt cardiac function 96
New biomarkers in community-acquired pneumonia: Another step in improving outcome prediction 95
Long-term macrolides in diffuse interstitial lung diseases 93
EBUS-TBNA nella patologia mediastino-polmonare: analisi retrospettiva dei primi 3 anni di attività di un singolo centro 91
Prevention of ventilator-associated pneumonia in the intensive care unit: a review of the clinically relevant recent advancements 88
European Respiratory Society International Congress 2017: highlights from the Clinical Assembly 88
Non-antibiotic therapies for CAP 87
Multidisciplinary approach to systemic diseases: benefits for diagnosis and management of complex disorders 86
Molecular biomarkers in idiopathic pulmonary fibrosis: State of the art and future directions 85
Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease Patients with Frequent Hospitalized Exacerbations: A Prospective Multicentre Study 82
Differences between acute exacerbations of idiopathic pulmonary fibrosis and other interstitial lung diseases 76
Idiopathic pulmonary fibrosis mortality in the Italian epicenter of COVID-19 pandemic 75
COVID-19. The Pulmonologist and the new scenarios on a new pandemic 74
Early recognition of airway obstruction in Fabry disease and correlation with dyspnea: A case series 73
Utility and safety of bronchoscopy during the SARS-CoV-2 outbreak in Italy: A retrospective, multicentre study 72
Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up Study 72
Feasibility and clinical impact of a portable bi-level ventilation device in patients with severe chronic obstructive pulmonary disease and exertional dyspnea: preliminary results from a clinical series 70
Utility of precipitating antibody testing in the diagnostic evaluation of chronic hypersensitivity pneumonia 69
How to choose the duration of antibiotic therapy in patients with pneumonia 69
Early outcomes in CAP: Clinical stability, clinical failure and nonresolving pneumonia 69
Feasibility of CPAP application and variables related to worsening of respiratory failure in pregnant women with SARS-CoV-2 pneumonia: Experience of a tertiary care centre 69
Healthcare costs and resources utilization in children with difficult-to-control asthma treated with biologic therapies: A population-based cohort study 66
Impact of N-acetyl-L-cysteine on SARS-CoV-2 pneumonia and its sequelae: results from a large cohort study 64
Effectiveness and economic impact of Dupilumab in asthma: a population-based cohort study 63
Nutrition in Patients with Idiopathic Pulmonary Fibrosis: Critical Issues Analysis and Future Research Directions 63
Interstitial pneumonia associated with autoimmune diseases: a possible mimicker of SARS-CoV-2 pneumonia 62
Re: Selective digestive decontamination saves lives whilst preventing resistance 60
Differences of Acute Exacerbations in Idiopathic Pulmonary Fibrosis compared to otherfibrotic lung diseases 60
A second update on mapping the human genetic architecture of COVID-19 59
RA-ILD: does more detailed radiological classification add something to our knowledge of this condition? 58
Interstitial Lung Disease and Anti-Myeloperoxidase Antibodies: Not a Simple Association 57
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study 54
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 54
Short-term Evolution of Nutritional Status in Patients with Idiopathic Pulmonary Fibrosis 53
Idiopathic pulmonary fibrosis beyond the lung: understanding disease mechanisms to improve diagnosis and management 48
Respiratory viruses in stable bronchiectasis: A multicenter evaluation in Northern Italy 45
Sarcopenia in idiopathic pulmonary fibrosis: a prospective study exploring prevalence, associated factors and diagnostic approach 41
Interstitial lung disease in ANCA-associated vasculitis: another step forward 39
Sleep-Disordered Breathing and Chronic Respiratory Infections: A Narrative Review in Adult and Pediatric Population 32
Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD 29
Immune-Checkpoint-Inhibitor-Related Lung Toxicity: A Multicentre Real-Life Retrospective Portrait from Six Italian Centres 24
Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for COVID-19: comment 20
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: comment 18
Totale 11.752
Categoria #
all - tutte 39.295
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.295


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019356 0 0 0 0 0 0 0 0 0 0 160 196
2019/20201.815 169 90 95 146 132 220 199 184 176 192 111 101
2020/20212.900 120 131 270 268 311 309 298 358 229 226 172 208
2021/20221.818 192 193 230 174 100 159 75 122 74 98 134 267
2022/20232.624 278 694 307 232 191 386 41 173 166 26 77 53
2023/20241.637 46 73 121 98 235 447 330 96 117 52 22 0
Totale 11.827